Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Merck & Co (NY:MRK)

90.95 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 62,934
Open 90.95
Bid (Size) 91.42 (100)
Ask (Size) 91.75 (100)
Prev. Close 90.95
Today's Range 90.95 - 90.95
52wk Range 73.31 - 105.07
Shares Outstanding 2,531,374,696
Dividend Yield 3.56%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Stocks Down 13% and 34% to Buy Right Now
It's been a year to forget for these two companies, but brighter days are ahead. 
Via The Motley Fool
Topics Intellectual Property World Trade
Google To Run Ohio Data Centers On Solar Power From TotalEnergies
TotalEnergies and Google have signed a 15-year PPA for renewable electricity. The deal aligns with both companies' goals. 
Via Benzinga

Performance

YTD
-8.3%
-8.3%
1 Month
+6.1%
+6.1%
3 Month
+13.3%
+13.3%
6 Month
+18.7%
+18.7%
1 Year
-9.7%
-9.7%

More News

Read More
Dow Jones Industrial Average Soars to Record High: A Nuanced Signal for the Economy
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Dow Jones Industrial Average Soars to New All-Time High Amidst Shifting Market Dynamics
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
Via StockStory
Topics Artificial Intelligence Stocks
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
What's going on in today's session: S&P500 movers
Via Chartmill
Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
Via The Motley Fool
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
Via MarketMinute
Topics Artificial Intelligence Economy Government
Cliff Asness: The Stock Market is Expensive, Not a Bubble – A Call for Rationality in a Less Efficient Market
Via MarketMinute
Topics Economy
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial
From Merck & Co., Inc.
Via Business Wire
Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%
Via Investor's Business Daily
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
From Merck & Co., Inc.
Via Business Wire
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
Herkimer College Pioneers New AI-Business Degree to Forge Future-Ready Workforce
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
3 Dirt Cheap Stocks to Buy With $1,000 Right Now
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
2 Safe-and-Steady Stocks Worth Your Attention and 1 We Turn Down
Via StockStory
ESG Investing's Future: Navigating Regulatory Currents and Sustainable Fund Performance
Via MarketMinute
Topics Artificial Intelligence Bonds Climate Change
Navigating the Volatility: Q3 2025 Earnings Season Delivers Both Cheers and Concerns
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
Via MarketMinute
Topics Intellectual Property
Merck & Co. Inc. (NYSE:MRK) Presents a Compelling Case for Dividend Investors
Via Chartmill
3 Reasons Investors Love Merck (MRK)
Via StockStory
Topics Stocks Supply Chain
MarketMinute: The Rise of Precision Swine Farming – A New Frontier in Agri-Tech Investment
Via MarketMinute
Topics Artificial Intelligence Supply Chain
Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars
Via MarketMinute
Topics Economy
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 90.95
When was Merck & Co last traded?
The last trade of Merck & Co was at 11/11/25 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 230.23B
How many shares of Merck & Co are outstanding?
Merck & Co has 230B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.